Persist helps pharma make drug injections that last up to 1 year.
Using robotics & AI, we reduce a 5-year drug formulation process to ~2 years.
Contact Us (founders@persist-ai.com) for a case-study formulation
To make injections we encapsulate drugs inside injectable microspheres made with FDA-approved materials.
Left: Image of a ~37 um microsphere made by our robotics
Right: A Schematic showing how encapsulated drugs are released over 1 year so patients don’t take as many injections.
For chronic diseases, most patients prefer 1 injection/yr rather than multiple injections per week.
However, making a long-lasting injection takes a lot of trial and error and the time between iterations is long.
Key challenges include:
We utilize custom robotics and AI to solve the problems with building microspheres.
Introduce us to friends who work in Pharma. Email founders@persist-ai.com
“Follow” us on LinkedIn
Help pharma develop slow release drugs faster
For a pharma company to develop a sustained-release (slow release) drug formulation takes about 3-5 years and $10M or more. This is because there are a lot of variables and scientists' intuition (aka guesswork) needed to arrive at the final formulation solution.
We will provide a service to pharma companies to develop their formulations for them 50% faster and cheaper than current methods. To do this we will screen formulations in high throughput using automation and train ML which can make better predictions based on data (rather than guesses).
This will enable pharma companies to get drugs to market faster and earn revenue sooner.